(85 days)
Not Found
No
The description focuses on data transmission and display software, with no mention of AI/ML algorithms for analysis or interpretation.
No.
The device is described as an accessory to EEG and PSG systems that transmits data for remote viewing by a clinician to aid in diagnosis. It does not directly provide therapy or therapeutic interventions.
No
The device transmits and displays EEG/PSG data, which aids in diagnosis, but it does not perform the diagnosis itself. It is an accessory to diagnostic systems.
Yes
The device description explicitly states, "The Live View Panel is software only and does not connect to the patient except through a cleared and currently marketed EEG or PSG device." It further details the software components and their functions, confirming it is a software-based system for remote viewing of data.
Based on the provided information, the Live View Panel is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Live View Panel Function: The Live View Panel's intended use and device description clearly state that it is an accessory to EEG and PSG systems. It transmits and displays physiological data (EEG and PSG waveforms) collected directly from the patient via a cleared and marketed EEG or PSG device. It does not perform any tests on samples taken from the body.
- Data Source: The data it processes originates from electrical signals measured from the patient's body, not from in vitro samples.
Therefore, the Live View Panel falls under the category of a medical device that processes and displays physiological signals, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Live View Panel is an accessory to EEG and PSG systems, intended to transmit EEG or PSG data to a remote location where the data can be viewed by a clinician to aid in diagnosis of epilepsies, sleep disorders, and other related disorders.
The Live View Panel is intended for use by medical personnel within a medical facility, clinic or nursing home, or outside a medical facility under the supervision of a medical professional. The Live View Panel is available for use on all patient populations, including adults and children as determined by the medical professional.
This device is not to be used to monitor life threatening situations.
This device is not to be used to control life supporting or life sustaining devices.
Product codes (comma separated list FDA assigned to the subject device)
GWQ, OLZ, OLV, OLT
Device Description
The Live View Panel (LVP) consists of several software components that allow remote viewing of digitized physiological waveforms and general patient information for the purpose of viewing EEG (electroencephalography) or PSG (polysomnography) patients in real time or in review. The software uses off-the-shelf and custom software components to manage multiple computer displays to facilitate the viewing of several patients simultaneously.
The Live View Panel consists of three software components. The Live View Panel Acquisition Interface Server (AIS) located on the acquisition system collects patient data from a recording machine and transmits this information over a network to a client machine. The Live View Panel client program receives this information and displays basic information in grid pattern along with other patients. The Live View Panel Monitor Controller program manages a bank of displays, each displaying a single patient. The Live View Panel grid mimics the physical locations of the monitors to allow the clinician manage and keep track of multiple patients displayed on the bank of displays.
The Live View Panel is software only and does not connect to the patient except through a cleared and currently marketed EEG or PSG device. A software module resides on the EEG or PSG device and sends patient data to a remote computer where another software module displays the data on an array of monitors. The software runs on off-the-shelf computers.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
all patient populations, including adults and children
Intended User / Care Setting
medical personnel within a medical facility, clinic or nursing home, or outside a medical facility under the supervision of a medical professional.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing Data Testing included: Software testing
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K113117, K080546, K062943, K120888
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.1400 Electroencephalograph.
(a)
Identification. An electroencephalograph is a device used to measure and record the electrical activity of the patient's brain obtained by placing two or more electrodes on the head.(b)
Classification. Class II (performance standards).
0
પાડ
510(k) Summary
| SUMMARY DATE: | AUG 09 2013 | |
|---|---|---|
| Monday May 13, 2013 | ||
| 510K SUBMITTER: | ||
| Neurotronics, Inc. | ||
| 3600 NW 43rd Street, Suite F1 | ||
| Gainesville, FL, 32606 | Phone: 352.372.9955 | |
| Fax : 815.550.2871 | ||
| Primary Contact: | ||
| Name: David Pezet | ||
| Email: david.pezet@neurotronics.com | Title: Quality Manager | |
| Phone: 352.372.9955 Ext 355 | ||
| Establishment Registration Number: | ||
| 1063925 |
DEVICE TYPE (COMMON NAME):
Non-Normalizing Quantitative Electroencephalograph Software
PROPRIETARY NAME OF THE DEVICE:
Live View Panel (LVP)
1
CLASSIFICATION:
:
Product Code:
| Product Code | Device | Regulation Description | Regulation Number |
|---|---|---|---|
| GWQ | Full-Montage Standard | ||
| Electroencephalograph | Electroencephalograph | 882.1400 |
:
Subsequent Product Code:
| Product
Code | Device | Regulation
Description | Regulation
Number |
|-----------------|----------------------------------------------------------------------------------------|---------------------------|----------------------|
| OLZ | Automatic Event Detection Software For
Polysomnograph With
Electroencephalograph | Electroencephalograph | 882.1400 |
| OLV | Standard Polysomnograph With
Electroencephalograph | Electroencephalograph | 882.1400 |
| OLT | Non-Normalizing Quantitative
Electroencephalograph Software | Electroencephalograph | 882.1400 |
PREDICATE DEVICES
| Submitter/Holder | Device Name | Model | 510(K) |
|---|---|---|---|
| Nihon Kohden America, Inc. | Nihon Kohden EEG-1200A Series | ||
| Neurofax | EEG-1200A | K080546 | |
| Neurotronics, Inc. | Polysmith Sleep System | NTI5498 | K062943 |
| Nihon Kohden Corp. | PSG-1100 Sleep Diagnostic System | PSG-1100 | K120888 |
| Nihon Kohden America, Inc. | Nihon Kohden EEG-1200A with JE- | ||
| 120A Multi Channel Electrode | |||
| Junction Box | JE-120A | K113117 |
2
DESCRIPTION
The Live View Panel (LVP) consists of several software components that allow remote viewing of digitized physiological waveforms and general patient information for the purpose of viewing EEG (electroencephalography) or PSG (polysomnography) patients in real time or in review. The software uses off-the-shelf and custom software components to manage multiple computer displays to facilitate the viewing of several patients simultaneously.
The Live View Panel consists of three software components. The Live View Panel Acquisition Interface Server (AIS) located on the acquisition system collects patient data from a recording machine and transmits this information over a network to a client machine. The Live View Panel client program receives this information and displays basic information in grid pattern along with other patients. The Live View Panel Monitor Controller program manages a bank of displays, each displaying a single patient. The Live View Panel grid mimics the physical locations of the monitors to allow the clinician manage and keep track of multiple patients displayed on the bank of displays.
The Live View Panel is software only and does not connect to the patient except through a cleared and currently marketed EEG or PSG device. A software module resides on the EEG or PSG device and sends patient data to a remote computer where another software module displays the data on an array of monitors. The software runs on off-the-shelf computers.
Image /page/2/Figure/4 description: The image shows a diagram of a system with multiple components. On the left side, there are four acquisition stations connected to a network switch. The data from the network switch is then transmitted to two live view panel (LVP) stations, each with its own network switch. Additionally, the data is sent via the internet to branch locations.
3
INTENDED USE
The Live View Panel is an accessory to EEG and PSG systems, intended to transmit EEG or PSG data to a remote location where the data can be viewed by a clinician to aid in diagnosis of epilepsies, sleep disorders, and other related disorders.
The Live View Panel is intended for use by medical personnel within a medical facility, clinic or nursing home, or outside a medical facility under the supervision of a medical professional. The Live View Panel is available for use on all patient populations, including adults and children as determined by the medical professional.
This device is not to be used to monitor life threatening situations.
This device is not to be used to control life supporting or life sustaining devices.
4
PREDICATE COMPARISON
Intended Use Comparison
The Live View Panel accessory improves upon the predicates' current capabilities for remote access and review of on-line or previously recorded acquisitions. This accessory does not change the indications for use for the devices which it is an accessory. This accessory is intended to aid in diagnosis of epilepsies, sleep disorders, and other related disorders.
Technical Comparison
The Live View Panel contains a subset of features found in the predicate. The device's main function is to facilitate the viewing of multiple patients' data from a location physically removed from the patient area. The Live View Panel extends the predicates' ability to view recordings remotely by providing an intuitive interface to manage multiple recordings. Therefore Neurotronics believes the Live View Panel is substantially equivalent to the Nihon Kohden EEG-1200A with JE-120A Multi Channel Electrode Junction Box (K113117), Nihon Kohden EEG-1200A Series Neurofax (K080546), PSG-1100 Sleep Diagnostic System (K120888), and Polysmith Sleep System, Model NTI5498 (K062943).
| Live View Panel | EEG Predicates
(K113117, K080546) | PSG Predicates
(K062943, K120888) |
|-------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------|--------------------------------------|
| Display Electrical activity of the brain and other
physiological signals on a monitor | Same | Same |
| Device uses Windows™ on a 32-bit computer | Same | Same |
| Display waveforms in acquisition and review | Same | Same |
| Maximum number of waveforms on screen is 64
(EEG) and 32 (PSG) | Same | Same |
| Simultaneously view waveforms from multiple
EEG/PSG instruments connected to a network
and display values from external instruments | Same | Same |
| Variable waveform display duration | Same | Same |
| Change waveform parameters (pattern, montage,
amplifier conditions, AV induction) | Same | Same |
| Add, edit, delete on screen events | Same | Same |
| The device can measure vital signs (including
ECG, EMG, Respiration, ocular motility, SpO2,
and CO2) | Same | Same |
| Display patient video along with waveforms | Same | Same |
| For use by medical personnel in a medical
facility, physician's office, laboratory, clinic, or
nursing home | Same | Same |
| Any patient population including adults and
children as determined by a trained professional | Same | Same |
5
PERFORMANCE DATA
. Testing Data Testing included: Software testing
CONCLUSION
Based on the results of the Intended Use Comparison, the Technical Comparison, and Testing Data, it is believed that the Live View Panel (LVP) accessory presents no new questions of safety and effectiveness and, is substantially equivalent to the features provided by the Nihon Kohden EEG-1200A with JE-120A Multi Channel Electrode Junction Box (K113117), Nihon Kohden EEG-1200A Series Neurofax (K080546), Polysmith Sleep System, Model NTI5498 (K062943), and PSG-1100 Sleep Diagnostic System (K120888).
6
Image /page/6/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of the department's name in a circular arrangement around a symbol. The symbol is a stylized representation of a human figure embracing a bird, often interpreted as representing the department's mission of protecting and promoting the health of Americans. The text reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA".
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002
August 9, 2013
Neurotronics, Inc. c/o Mr.David Pezet Quality Manager 3600 NW 43td Street, Suite Fl Gainesville, FL 32606
Re: K131415
Trade/Device Name: Live View Panel Regulation Number: 21 CFR 882.1400 Regulation Name: Standard polysomnograph with electroencephalograph Product Code: OLV, GWQ, OLZ, and OLT Dated: June 16, 2013 Received: June 17, 2013
Dear Mr. Pezet:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing
7
Page 2 - Mr. David Pezet
practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Joyce M. Whang -S
for Victor Krauthamer, Ph.D. Acting Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
8
Indications for Use
510(k) Number (if known): K131415
Device Name:
Indications For Use:
The Live View Panel is an accessory to EEG and PSG systems, intended to transmit EEG or PSG data to a remote location where the data can be viewed by a clinician to aid in diagnosis of epilepsies, sleep disorders, and other related disorders
The Live View Panel is intended for use by medical personnel within a medical facility, clinic or nursing home, or outside a medical facility under the supervision of a medical professional. The Live View Panel is available for use on all patient populations, including adults and children as determined by the medical professional.
This device is not to be used to monitor life threatening situations.
This device is not to be used to control life supporting or life sustaining devices.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Division Sian Off) Division of Neurological and Physical Medicine Devices (DNPMD)
510(k) Number ________________________________________________________________________________________________________________________________________________________________ K131415
Page 1 of 1